97267-35-1

Basic information

• Product Name: 5-Benzyl-1-oxa-5-azaspiro[2.5]octane
• Synonyms: 5-Benzyl-1-oxa-5-azaspiro[2.5]octane
• CAS NO: 97267-35-1
• Molecular Formula: C₁₃H₁₇NO
• Molecular Weight: 203
• Mol File: 97267-35-1.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 301℃
• Flash Point: 89℃
• Appearance: /
• Density: 1.12
• CAS DataBase Reference: 5-Benzyl-1-oxa-5-azaspiro[2.5]octane(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Benzyl-1-oxa-5-azaspiro[2.5]octane(97267-35-1)
• EPA Substance Registry System: 5-Benzyl-1-oxa-5-azaspiro[2.5]octane(97267-35-1)

Safety Data

• Hazardous Substances Data: 97267-35-1(Hazardous Substances Data)

Upstream product

• 40114-49-6 1-benzyl-3-piperidone 
• 70775-39-2 dimethylsulfoxonium methylide 
• 1774-47-6 trimethylsulfoxonium iodide 
• 50606-58-1 N-benzyl-3-piperidinone hydrochloride 
• 96042-30-7 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 
• 2181-42-2 trimethylsulphonium iodide 

Downstream Products

• 104778-55-4 1-benzyl-3-<(2-ethoxyphenoxy)methyl>-3-piperidinol 
• 104778-56-5 1-acetyl-3-<(2-ethoxyphenoxy)methyl>-3-piperidinol 
• 104778-52-1 3-<(2-ethoxyphenoxy)methyl>-3-piperidinol 
• 112197-89-4 3-hydroxy-3-(hydroxymethyl)-1-(phenylmethyl)piperidine 
• 405089-24-9 1-benzyl-3-(4-trifluoromethyl-phenoxymethyl)-piperidin-3-ol 
• 885268-85-9 C₁₃H₂₀N₂O 

Relevant articles and documents

PROGRANULIN MODULATORS AND METHODS OF USING THE SAME

Provided herein are compounds of formula (I) that modulate progranulin and methods of using the compounds in progranulin- associated disorders, such as Frontotemperal lobe dementia (FTLD).

QUINOLONE ANTIBACTERIAL AGENTS

Compounds of formula (I, II, III, IV, V, and VI) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula (I) as disclosed herein can be used in a variety of applications including use as antibacterial agents.

Method of treating addiction or dependence using a ligand for a monoamine receptor or transporter

One aspect of the present invention relates to a method of treating of drug addiction or drug dependence in a mammal, comprising the step of administering to a mammal in need thereof a therapuetically effective amount of a heterocyclic compound, e.g., a 3-substituted piperidine. In a preferred embodiment, the method of the present invention treats cocaine addiction or methamphetamine addiction.